Notify me when New Enterprise Associates 15, L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SNTI | Senti Biosciences, Inc. | Common Stock, $0.0001 par value | 14% | $11,968,700 | 3,775,615 | New Enterprise Associates 15, L.P. | 06 Mar 2025 | ||
| ACLX | Arcellx, Inc. | Common Stock $0.001 par value per share | 5.3% | $208,192,230 | 3,055,360 | 0% | Scott D. Sandell | 22 Feb 2026 | |
| NEUE | NeueHealth, Inc. | Common Stock, $0.0001 par value | 0% | $0 | -$50,344,650 | 0 | -100% | New Enterprise Associates 15, L.P. | 02 Oct 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|